35Pharma 
Welcome,         Profile    Billing    Logout  
  Products    Diseases   Products    Trials    News 
2 Trials

   

Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
HS135 / 35Pharma
NCT06493461: A Study of HS135 for the Treatment of Pulmonary Arterial Hypertension in Adults

Not yet recruiting
1
24
Canada
HS135
35Pharma Inc
Pulmonary Arterial Hypertension (PAH)
02/26
04/27
NCT06581159: Study of HS135 in Obese Patients with Pulmonary Hypertension and Heart Failure with Preserved Ejection Fraction

Not yet recruiting
1
30
NA
35Pharma Inc
Heart Failure with Preserved Ejection Fraction, Pulmonary Hypertension
04/26
06/27

Download Options